diet physical activity*intensive behavioral lifestyle*comprehensive weight maintenance*behavioral lifestyle intervention*necessary energy deficit*loss such program*loss sustained weight
nonsurgical subject*lifelong lifestyle support
aglucosidase*alpha glucosidase*aglucosidase inhibitor*diet physical activity
min week minimum*goal metformin*longstanding evidence base*min week*goal metformin monotherapy*glycemic goal metformin
ongoing glycemia reduction*inhibitor glp1 analog*inhibitor glp1*glp1 analog*sulfonylurea dpp4*class sulfonylurea dpp4*effectiveness study grade*irregular meal schedule*ongoing glycemia*class sulfonylurea*dpp4 inhibitor glp1*secretagogues meglitinides*drug class sulfonylurea*sulfonylurea dpp4 inhibitor*catabolic feature*catabolic feature weight
serial lung function*insulin analog people*dos adjunctive use*noninsulin agent*inhibitor glp1*analog people*sulfonylurea dpp4*combination injectable therapy*prandial use*dpp4 inhibitor glp1*goal provider*glycemic goal provider*limited dosing range*sulfonylurea dpp4 inhibitor*regimen flexibility
min week
